Management Team
Mr. Carlo Bellini
Dr. Francesco Bellini is Chairman and CEO at Klox Technologies Inc. He is a renown healthcare investor in Canada who has successfully exited multiple ventures including BioChem Pharma, ViroChem Pharma, and FB Health.
Dr. Francesco Bellini is an Officer of the Order of Canada and a Cavalieri del Lavoro of Italy. He was the co-founder and Chief Executive Officer of BioChem Pharma Inc., a biopharmaceutical company focused on infectious diseases (HIV), diagnostics and vaccine technology, which was ultimately merged with Shire Plc in 2001. Dr. Bellini received his Bachelor of Science degree from Concordia University and his PhD in organic chemistry from the University of New Brunswick.
Mr. Carlo Bellini
Mr. Carlo Bellini is President of Klox Technologies Inc. He joined the senior management team in 2017. Prior to joining KTI, Mr. Bellini was Managing Director of Vitus Capital Holdings Ltd., a private U.K. Venture Fund. Mr. Bellini has worked in various capacities at multiple investment funds throughout his carrier. Mr. Bellini received his Bachelor of Arts in Finance from McGill University. He holds a Bachelor of Arts in Finance from McGill University.
Dr. Lise Hébert
Dr. Lise Hébert is SVP Research and Clinical Affairs of Klox Technologies Inc. She holds a PhD in Experimental Medicine from McGill University, and completed her post-doctoral studies at the Lady Davis Research Institute at the Montreal Jewish General Hospital. She is the author of several patents and currently serves on the Life Sciences Committee of the Fédération des Chambres du Commerce du Québec.
Mr. Joseph D'Abramo
Mr. Joseph D’Abramo, CPA, CA is SVP Finance, HR and Supply Chain of Klox Technologies Inc. He is a Chartered Professional Accountant and holds a Bachelor of Commerce (BComm) and Graduate Diploma (CA) from the John Molson School of Business at Concordia University. He previously spent 10 years at Deloitte & Touche before joining Klox.
Dr. Michael Nielsen
Dr. Michael Nielsen is SVP & Chief Science Officer at Klox Asia Holdings Limited. Prior to joining Klox Asia, Dr. Nielsen was SVP Clinical & Medical Scientific Affairs at Klox. Dr. Nielsen was formerly from LEO Pharma, along with being an associate professor from the Danish Technical University, and Copenhagen University. Dr. Nielsen is specialized in cellular biology, and immunology.
Dr. Daniela Jukic
Dr. Daniela Jukic is Senior Director, Regulatory Affairs, Compliance and Quality Assurance at Klox Technologies Inc. She holds a PhD in Pharmacology from the Faculty of Medicine at the University of Sherbrooke, and provides +20 years of experience from Pfizer/Pharmacia, Merck Canada, Schering Canada/Bayer and at Hema-Quebec.